Phase I Safety, Tolerability, and Pharmacokinetic Study of Recombinant Human Mannan-Binding Lectin

Author: Petersen Kenneth   Matthiesen Finn   Agger Teit   Kongerslev Leif   Thiel Steffen   Cornelissen Karen   Axelsen Mads  

Publisher: Springer Publishing Company

ISSN: 0271-9142

Source: Journal of Clinical Immunology, Vol.26, Iss.5, 2006-09, pp. : 465-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content